Therapeutic drugs
Toceranib Phosphate Tablets
Lucpets (Jinan) Animal Healthcare Co., Ltd.
Price on request
Contact us for pricing, specifications and order requirements.
Add products to request a quote. Pricing is confirmed with our team.
Product Highlights
- Product informationReview the original specifications and details below.
Product Details
Product Name: Toceranib Phosphate Tablets
Strength: 10mg/tablet , 15mg/tablet , 50mg/tablet
Package: 10 tablets per blister strip.
For Use In: Dogs.
Main component: Each tablet contains 10 mg, 15 mg, or 50 mg of Toceranib (as Toceranib Phosphate).
Actions & Indications:
Toceranib is a selective receptor tyrosine kinase inhibitor primarily targeting KIT, PDGFR, and VEGFR. By inhibiting these signaling pathways crucial for tumor cell proliferation, survival, and angiogenesis, it exerts an antitumor effect.
Indicated for the treatment of recurrent or metastatic canine mast cell tumors (MCT), particularly in cases where complete surgical excision is not possible or metastasis has occurred.
Dosage: For oral use only.
Administration with food is recommended to reduce gastrointestinal irritation.
Recommended Dosage: 3.25 mg/kg body weight, administered every other day (e.g., Monday, Wednesday, Friday).
| Dog Body Weight | Number of Tablets | ||||
| Pounds | kg | Dose | 10mg | 15mg | 50mg |
| 11.0-11.8 | 5.0-5.3 | 15mg | 1 | ||
| 11.9-15.2 | 5.4-6.9 | 20mg | 2 | ||
| 15.3-18.5 | 7.0-8.4 | 25mg | 1 | 1 | |
| 18.6-22.0 | 8.5-10.0 | 30mg | 2 | ||
| 22.1-25.4 | 10.1-11.5 | 35mg | 2 | 1 | |
| 25.5-28.7 | 11.6-13.0 | 40mg | 1 | 2 | |
| 28.8-32.2 | 13.1-14.6 | 45mg | 3 | ||
| 32.3-35.5 | 14.7-16.1 | 50mg | 1 | ||
| 35.6-38.8 | 16.2-17.6 | 55mg | 1 | 3 | |
| 38.9-42.3 | 17.7-19.2 | 60mg | 1 | 1 | |
| 42.4-45.6 | 19.3-20.7 | 65mg | 1 | 1 | |
| 45.7-50.7 | 20.8-23.0 | 70mg | 2 | 1 | |
| 50.8-59.3 | 23.1-26.9 | 80mg | 2 | 1 | |
| 59.4-65.9 | 27.0-29.9 | 95mg | 3 | 1 | |
| 66.0-71.2 | 30.0-32.3 | 100mg | 2 | ||
| 71.3-76.3 | 32.4-34.6 | 110mg | 1 | 2 | |
| 76.4-79.6 | 34.7-36.1 | 115mg | 1 | 2 | |
| 79.7-84.7 | 36.2-38.4 | 120mg | 2 | 2 | |
| 84.8-94.8 | 38.5-43.0 | 130mg | 2 | 2 | |
| 94.9-105.0 | 43.1-47.6 | 150mg | 3 | ||
| 105.1-110.0 | 47.7-49.9 | 160mg | 1 | 3 | |
| 110.1-113.5 | 50.0-51.5 | 165mg | 1 | 3 | |
| 113.6-118.6 | 51.6-53.8 | 170mg | 2 | 3 | |
| 118.7-128.8 | 53.9-58.4 | 180mg | 2 | 3 | |
| 128.9-138.9 | 58.5-63.0 | 200mg | 4 | ||
| 139.0-144.0 | 63.1-65.3 | 210mg | 1 | 4 | |
Dosage Adjustment:
The starting dose is typically 3.25 mg/kg every other day. Your veterinarian will fine-tune the dose within the recommended range based on the individual dog's tolerance (particularly to adverse effects) and therapeutic response.
Treatment Course:
Treatment should continue until disease progression or intolerable toxicity occurs. Do not discontinue or alter the dosing schedule without veterinary instruction.
Contraindications & Warnings:
Absolute Contraindications:
Hypersensitivity to toceranib or any excipient.
Dogs with severe hepatic impairment.
Dogs with active, severe gastrointestinal bleeding or ulceration.
STRICTLY PROHIBITED for use in humans, cats, or other animals.
Relative Contraindications / Use with Caution:
Mild to moderate hepatic impairment.
Renal insufficiency.
History of cardiac disease.
Concurrent use with NSAIDs or corticosteroids may increase the risk of gastrointestinal toxicity and renal injury.
Reproductive Safety:Safety in pregnant, lactating bitches or breeding stud dogs has not been established.
Contraindicated.
Adverse Reactions
Common adverse reactions are related to its mechanism of action and are often manageable with dose adjustments or supportive care.
Very Common (>10%):Diarrhea, vomiting, decreased appetite, lethargy, weight loss, hypoproteinemia
(hypoalbuminemia).
Common (1-10%):Gastrointestinal hemorrhage (melena, hematochezia), pancreatitis, elevated liver enzymes, neutropenia, thrombocytopenia, proteinuria, hypertension, footpad fissures/pain.
Uncommon but Serious:Gastrointestinal perforation, severe hemorrhage, nephrotic syndrome, heart failure, arterial thromboembolism.
Monitoring Requirements:Regular monitoring (e.g., every 2-4 weeks) with complete blood count (CBC), serum biochemistry (focus on liver and kidney function, electrolytes, albumin), and urinalysis is required during treatment.
Drug Interactions
CYP450 Enzyme Substrate Drugs:Toceranib may affect the plasma concentrations of drugs metabolized by
CYP3A4, 2B11, and 2D15.
Highly Protein-Bound Drugs:Displacement interactions may occur, affecting the plasma concentrations of each drug.
Anticoagulants (e.g., Warfarin):Increases the risk of bleeding.
QT-Prolonging Drugs:Concurrent use may increase the risk of arrhythmia.
Inform your veterinarian of all medications (including prescription, over-the-counter, and supplements) the dog is
receiving.

ABOUT LUCPETS
Company Profile
Lucpets (Jinan) is committed to animal healthcare, focusing on the research and development, production and promotion of pet food, health products, diagnostic reagents and animal medicines. Our mission is to be the health guardian of your animal companion.
Our professional R&D team comprises 4 PhDs, 4 master’s degree holders, and other qualified researchers. Our laboratory is equipped with HPLC systems, GC systems and stability testing equipment to support product development and quality research.
More about Lucpets →Production & quality
Three production bases cover animal food, health supplements, veterinary pharmaceuticals and active pharmaceutical ingredients. Product quality standards and documentation can be discussed for your project.
OEM & ODM services
We evaluate production based on the formulas and requirements provided by the client, and work together to develop product concepts and project plans.
Contact & location
Capital Building, Licheng District, Jinan City, Shandong Province, P.R. China
sales@lucpets.comFrequently Asked Questions
How can I get product specifications and pricing?
Send an inquiry with the product name, specification and quantity you need. Our team will confirm the product information, availability and quotation.
Do you provide OEM and ODM services?
Yes. For OEM, we evaluate production based on the formulas and requirements provided by the client. For ODM, we work with the client to develop product concepts and project plans tailored to their specific needs.
How long do custom projects take?
Requirement confirmation typically takes 1–3 business days, solution development takes 3–5 business days, and sample approval takes 7–10 business days. Timelines for mass production depend on the specific product and order volume.
What should I do if I encounter a product quality issue?
Please provide your order details, the product batch number, and a description of the issue. We will investigate the matter and provide a resolution based on the specific situation.

